Cargando…
Plasma MIR-212-3p as a biomarker for acute right heart failure with pulmonary artery hypertension
BACKGROUND: Acute right heart failure occurs in patients with pulmonary artery hypertension (PAH) with exposure to acute inflammation, the mortality rate is very high when right heart failure occurs. Biomarkers that can be used to detect acute right heart failure in patients with pulmonary hypertens...
Autores principales: | Yang, Yue, Li, Renhua, Cao, Yanan, Dai, Sisi, Luo, Sumei, Guo, Qulian, Wang, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791226/ https://www.ncbi.nlm.nih.gov/pubmed/33437770 http://dx.doi.org/10.21037/atm-20-1653a |
Ejemplares similares
-
Regulation of the Immune Microenvironment by an NLRP3 Inhibitor Contributes to Attenuation of Acute Right Ventricular Failure in Rats with Pulmonary Arterial Hypertension
por: Guo, Lizhe, et al.
Publicado: (2021) -
Levosimendan in pulmonary hypertension and right heart
failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018) -
Lipopolysaccharide acutely suppresses right-ventricular strain in rats with pulmonary artery hypertension
por: Zhang, Junjie, et al.
Publicado: (2017) -
Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2022) -
Right heart in pulmonary hypertension: from adaptation to
failure
por: Ren, Xianfeng, et al.
Publicado: (2019)